414 related articles for article (PubMed ID: 19031695)
1. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
[TBL] [Abstract][Full Text] [Related]
2. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
Jaiswal S; Khanna N; Swaminathan S
Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
4. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
5. Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes.
Khanam S; Etemad B; Khanna N; Swaminathan S
Am J Trop Med Hyg; 2006 Feb; 74(2):266-77. PubMed ID: 16474083
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates.
Bernardo L; Izquierdo A; Alvarez M; Rosario D; Prado I; López C; Martínez R; Castro J; Santana E; Hermida L; Guillen G; Guzmán MG
Antiviral Res; 2008 Nov; 80(2):194-9. PubMed ID: 18602424
[TBL] [Abstract][Full Text] [Related]
7. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein.
Mota J; Acosta M; Argotte R; Figueroa R; Méndez A; Ramos C
Vaccine; 2005 May; 23(26):3469-76. PubMed ID: 15837370
[TBL] [Abstract][Full Text] [Related]
8. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
[TBL] [Abstract][Full Text] [Related]
9. [Expression and function analysis of dengue virus type 1 to 4 envelope domain III recombinant fusion protein].
Niu GY; Lu P; Zhang S; Zhang QF; Li C; Liang MF; Xu F; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):161-4. PubMed ID: 21186514
[TBL] [Abstract][Full Text] [Related]
10. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
[TBL] [Abstract][Full Text] [Related]
11. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
Sim AC; Lin W; Tan GK; Sim MS; Chow VT; Alonso S
Vaccine; 2008 Feb; 26(9):1145-54. PubMed ID: 18243432
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of recombinant soluble dengue virus 2 envelope domain III protein production in Escherichia coli trxB and gor double mutant.
Saejung W; Puttikhunt C; Prommool T; Sojikul P; Tanaka R; Fujiyama K; Malasit P; Seki T
J Biosci Bioeng; 2006 Oct; 102(4):333-9. PubMed ID: 17116581
[TBL] [Abstract][Full Text] [Related]
13. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
Khanam S; Khanna N; Swaminathan S
Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
[TBL] [Abstract][Full Text] [Related]
14. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
[TBL] [Abstract][Full Text] [Related]
15. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses.
Brandler S; Ruffie C; Najburg V; Frenkiel MP; Bedouelle H; Desprès P; Tangy F
Vaccine; 2010 Sep; 28(41):6730-9. PubMed ID: 20688034
[TBL] [Abstract][Full Text] [Related]
16. Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice.
Zulueta A; Martín J; Hermida L; Alvarez M; Valdés I; Prado I; Chinea G; Rosario D; Guillén G; Guzmán MG
Virus Res; 2006 Oct; 121(1):65-73. PubMed ID: 16781791
[TBL] [Abstract][Full Text] [Related]
17. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
18. Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein.
Chen S; Yu M; Jiang T; Deng Y; Qin C; Qin E
DNA Cell Biol; 2007 Jun; 26(6):361-7. PubMed ID: 17570760
[TBL] [Abstract][Full Text] [Related]
19. A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates.
Hermida L; Bernardo L; Martín J; Alvarez M; Prado I; López C; Sierra Bde L; Martínez R; Rodríguez R; Zulueta A; Pérez AB; Lazo L; Rosario D; Guillén G; Guzmán MG
Vaccine; 2006 Apr; 24(16):3165-71. PubMed ID: 16490289
[TBL] [Abstract][Full Text] [Related]
20. Application of antibodies against nonstructural protein 2B of dengue serotype 2 virus induced by DNA immunisation or recombinant protein NS 2B immunisation in BALB/c mice.
Liu L; Tian Y; Gao N; Chen Zt; Zhang H; An J
J Virol Methods; 2010 Jan; 163(1):10-6. PubMed ID: 19406165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
